Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in northwest Ethiopia

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Adane, Akilew Awoke ^a   Alene, Kefyalew Addis ^a   Koye, Digsu Negese ^a   Zeleke, Berihun Megabiaw ^a  

^a UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ETHIOPIA; FACTORIAL ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT ATTITUDE; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT REFUSAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; URBAN POPULATION;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; ETHIOPIA; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 84892938450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078791     Document Type: Article

References (21)

1. Fauci A, Kasper D, Braunwald E (2008) Tuberculosis Harrison's principle of internal medicine 17th ed. United States of America: The McGraw-Hill Companies.
2. Organization WH (2012) WHO policy on collaborative TB/HIV activities Guidelines for national programmes and other stakeholders. Geneva, Switzerland. 36 p.
3. Organisation WH (2011) WHO Report 2011 | Global Tuberculosis Control. France WHO. 258 p.
4. Ethiopia FMoH (2008) Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme. Addis Ababa, Ethiopia 207 p.
5. Sabate E (2003) Adhernece to long-term therapies: Evidence for action. Geneva, Switzerland: WHO.
6. Harries A, Maher D, Graham S (2004) TB/HIV:A CLINICAL MANUAL. Genva World Health Organization 212 p.
7. Awofeso N (2008) Antituberculous medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bulletin of WHO 86.
8. Castelnuovo B (2010) A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 10: 320-324.
9. Organization WH (2010) Antiretroviral therapy for HIV infection in adults and adolescents recommendations for a public health approach. Geneva Siwzerland WHO.
10. de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, Aarnoutse RE, et al. (2012) Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56: 4937-4944.
11. Rocha M, Pereira S, Ferreira L, Barros H (2003) The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J 21: 785-788. (Pubitemid 36592285)
12. Kebede A, Wabe NT (2012) Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. N Am J Med Sci 4: 67-71.
13. Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN (2009) Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. Afr Health Sci 9 Suppl 1: S8-15.
14. Sardar P, Jha A, Roy D, Roy S, Guha P, et al. (2010) Intensive phase noncompliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study. J Community Health 35: 471-478.
15. Weiguo X, Wei L, Zhou Y, Zhu L, Shen H, et al. (2009) Adherence to antituberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Services Research 9: 1472-6963.
16. Gebremariam MK, Bjune GA, Frich JC (2010) Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health 10: 651.
17. Shargie EB, Lindtjorn B (2007) Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med 4: e37.
18. Garrido Mda S, Penna ML, Perez-Porcuna TM, de Souza AB, Marreiro Lda S, et al. (2012) Factors associated with tuberculosis treatment default in an endemic area of the brazilian Amazon: a case control-study. PLoS One 7: e39134.
19. Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, et al. (2011) Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health 11: 696.
20. Govender S, Mash R (2009) What are the reasons for patients not adhering to their anti-TB treatment in a South African district hospital? SA Fam Pract 51: 512-516.
21. Abula T, Worku A (2001) patient non compliance with drug regimens for chronic diseaes in northweat Ethiopia. EthiopJHealth Dev 15: 185-192.